Index - P/E 85.47 EPS (ttm) 3.86 Insider Own 2.07% Shs Outstand 36.99M Perf Week 0.31%
Market Cap 12.38B Forward P/E 53.39 EPS next Y 6.18 Insider Trans -15.32% Shs Float 36.73M Perf Month 2.89%
Income 147.28M PEG 3.42 EPS next Q 0.99 Inst Own 94.49% Short Float 4.00% Perf Quarter 42.38%
Sales 730.23M P/S 16.95 EPS this Y 26.01% Inst Trans -3.92% Short Ratio 1.35 Perf Half Y 59.99%
Book/sh 18.08 P/B 18.26 EPS next Y 27.40% ROA 13.24% Short Interest 1.47M Perf Year 17.70%
Cash/sh 26.41 P/C 12.50 EPS next 5Y 25.00% ROE 24.96% 52W Range 157.00 - 331.58 Perf YTD 73.17%
Dividend Est. - P/FCF 74.81 EPS past 5Y - ROI 10.26% 52W High -0.48% Beta 1.08
Dividend TTM - Quick Ratio 10.73 Sales past 5Y 142.68% Gross Margin 86.94% 52W Low 110.19% ATR (14) 3.63
Dividend Ex-Date - Current Ratio 11.76 EPS Y/Y TTM -33.01% Oper. Margin 22.42% RSI (14) 75.19 Volatility 0.46% 0.60%
Employees 1468 Debt/Eq 1.15 Sales Y/Y TTM 49.11% Profit Margin 20.17% Recom 3.00 Target Price 294.27
Option/Short Yes / Yes LT Debt/Eq 1.15 EPS Q/Q -68.72% Payout 0.00% Rel Volume 0.57 Prev Close 329.84
Sales Surprise 1.78% EPS Surprise 30.31% Sales Q/Q 40.93% Earnings May 06 AMC Avg Volume 1.09M Price 330.00
SMA20 0.64% SMA50 10.84% SMA200 41.78% Trades
Volume 619,823 Change 0.05%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-05-24 Downgrade Wolfe Research
Outperform → Peer Perform
Mar-27-24 Initiated CL King
Buy
$368
Sep-29-23 Initiated UBS
Neutral
$218
Jul-10-23 Upgrade Morgan Stanley
Equal-Weight → Overweight
$291 → $335
May-30-23 Resumed Morgan Stanley
Equal-Weight
$291
Mar-15-23 Initiated Needham
Buy
$240
Dec-16-22 Initiated Deutsche Bank
Buy
$285
Dec-12-22 Downgrade Wells Fargo
Overweight → Equal Weight
$300 → $235
Sep-06-22 Downgrade Oppenheimer
Perform → Underperform
$165
Apr-06-22 Initiated Wolfe Research
Outperform
$255
Mar-02-22 Resumed BofA Securities
Buy
$200
Dec-06-21 Upgrade Wells Fargo
Equal Weight → Overweight
$235
Jul-15-21 Initiated SVB Leerink
Outperform
$208
Jul-12-21 Downgrade BofA Securities
Buy → Neutral
$180 → $200
Jun-18-21 Downgrade Wells Fargo
Overweight → Equal Weight
$189
May-11-21 Upgrade Piper Sandler
Neutral → Overweight
$134 → $165
May-11-21 Upgrade BofA Securities
Neutral → Buy
$180
Jan-20-21 Downgrade Piper Sandler
Overweight → Neutral
$96 → $132
Dec-01-20 Downgrade BofA Securities
Buy → Neutral
$105
Jun-11-20 Upgrade Oppenheimer
Underperform → Perform
Show Previous Ratings
Apr-25-24 06:15PM
Apr-24-24 07:27AM
Apr-22-24 02:49PM
Apr-21-24 10:39AM
Apr-19-24 06:15PM
01:49PM
Loading…
Apr-16-24 01:49PM
10:46AM
10:11AM
04:22AM
Apr-15-24 12:10PM
Apr-12-24 06:23AM
06:12AM
04:03AM
Apr-10-24 05:45PM
04:57AM
10:59AM
Loading…
Apr-09-24 10:59AM
Apr-08-24 04:03PM
Apr-06-24 08:15AM
12:01AM
(The Wall Street Journal)
Apr-05-24 04:13PM
(Investor's Business Daily)
04:13PM
(The Wall Street Journal)
03:27PM
01:10PM
(Investor's Business Daily)
12:37PM
(The Wall Street Journal)
12:25PM
(Associated Press Finance)
12:12PM
(Investor's Business Daily)
11:52AM
11:07AM
10:49AM
(Investor's Business Daily)
10:40AM
09:59AM
Loading…
09:59AM
09:31AM
08:56AM
(Associated Press Finance)
07:24AM
06:41AM
06:39AM
06:36AM
06:31AM
Apr-01-24 10:01AM
Mar-29-24 09:00AM
Mar-28-24 10:02AM
Mar-27-24 04:19PM
03:07PM
(Investor's Business Daily)
01:25PM
06:41AM
Mar-26-24 05:24PM
04:24PM
04:15PM
(The Wall Street Journal)
02:33PM
02:30PM
(The Wall Street Journal)
02:23PM
08:30AM
Mar-22-24 06:16AM
Mar-16-24 02:10AM
Mar-08-24 01:30AM
Mar-04-24 11:23AM
07:21AM
(Investor's Business Daily)
Feb-28-24 03:08AM
Feb-23-24 12:00PM
Feb-22-24 11:54PM
Feb-17-24 11:20AM
(Investor's Business Daily)
12:08AM
Feb-16-24 09:37AM
09:23AM
08:51AM
(Thomson Reuters StreetEvents)
Feb-15-24 10:00PM
05:20PM
04:40PM
04:20PM
(Associated Press Finance)
04:03PM
Feb-08-24 03:23AM
Feb-07-24 03:11AM
Feb-03-24 01:01AM
Jan-30-24 06:31AM
Jan-29-24 11:02PM
08:30AM
Jan-18-24 11:00PM
Jan-12-24 09:37AM
09:23AM
05:02AM
Jan-11-24 09:22AM
Jan-09-24 09:02AM
Jan-08-24 08:00AM
Jan-03-24 09:12AM
Dec-29-23 07:01PM
Dec-26-23 06:56PM
Dec-20-23 08:30AM
Dec-19-23 11:02AM
Dec-18-23 05:08AM
Dec-13-23 07:18AM
Dec-06-23 11:30AM
Dec-01-23 06:44AM
Nov-30-23 05:58AM
Nov-29-23 07:04AM
Nov-22-23 09:04AM
Nov-20-23 08:48AM
Nov-18-23 07:04AM
Nov-15-23 08:30AM
Nov-12-23 08:18AM
Nov-09-23 08:30AM
Shockwave Medical, Inc. operates as a medical device company, which concentrates on developing and commercializing products intended to transform the way classified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
FRANCIS LAURA Director Mar 26 '24 Option Exercise 6.59 1,500 9,882 2,733 Mar 27 08:04 PM Zacharias Isaac President, CCO Mar 26 '24 Sale 287.67 4,000 1,150,680 56,818 Mar 27 08:02 PM FRANCIS LAURA Director Mar 26 '24 Sale 300.00 1,500 450,000 3,551 Mar 27 08:04 PM WATKINS FRANK T Director Mar 06 '24 Option Exercise 3.42 2,000 6,832 6,532 Mar 07 09:26 PM WATKINS FRANK T Director Mar 06 '24 Sale 253.65 2,000 507,294 4,532 Mar 07 09:26 PM Phung Trinh VP, Finance Mar 06 '24 Sale 253.14 21 5,316 31,024 Mar 06 09:10 PM Zacharias Isaac President, CCO Feb 26 '24 Sale 260.36 4,000 1,041,440 61,372 Feb 27 08:50 PM Phung Trinh VP, Finance Feb 22 '24 Sale 259.24 599 155,285 31,031 Feb 22 08:13 PM MOLL FREDERIC H Director Feb 21 '24 Sale 257.39 60,000 15,443,412 287,521 Feb 22 08:15 PM FRANCIS LAURA Director Feb 16 '24 Option Exercise 6.59 1,000 6,588 2,233 Feb 20 08:11 PM FRANCIS LAURA Director Feb 16 '24 Sale 250.00 1,000 250,000 3,551 Feb 20 08:11 PM Godshall Douglas Evan President & CEO Feb 15 '24 Option Exercise 3.42 10,000 34,160 172,762 Feb 16 08:02 PM Godshall Douglas Evan President & CEO Feb 15 '24 Sale 231.56 10,000 2,315,599 162,762 Feb 16 08:02 PM MOLL FREDERIC H Director Feb 08 '24 Option Exercise 0.61 81,967 50,000 347,521 Feb 09 08:07 PM WATKINS FRANK T Director Feb 06 '24 Option Exercise 3.42 2,000 6,832 6,532 Feb 07 08:16 PM WATKINS FRANK T Director Feb 06 '24 Sale 231.76 2,000 463,518 4,532 Feb 07 08:16 PM Phung Trinh VP, Finance Feb 06 '24 Sale 232.18 1,287 298,821 32,933 Feb 07 08:17 PM PUCKETT DAN Chief Financial Officer Feb 05 '24 Sale 231.15 3,229 746,393 21,005 Feb 06 08:10 PM PUCKETT DAN Chief Financial Officer Feb 01 '24 Sale 229.76 3,406 782,577 27,732 Feb 02 08:03 PM Zacharias Isaac President, CCO Jan 26 '24 Option Exercise 6.71 4,000 26,840 67,920 Jan 29 08:08 PM Zacharias Isaac President, CCO Jan 26 '24 Sale 224.69 4,000 898,760 63,920 Jan 29 08:08 PM Zacharias Isaac President, CCO Jan 17 '24 Option Exercise 5.33 17,921 95,498 63,920 Jan 17 08:17 PM Godshall Douglas Evan President & CEO Jan 16 '24 Option Exercise 3.42 10,000 34,160 151,057 Jan 18 08:15 PM Godshall Douglas Evan President & CEO Jan 16 '24 Sale 217.59 10,000 2,175,858 141,057 Jan 18 08:15 PM WATKINS FRANK T Director Jan 08 '24 Option Exercise 3.42 2,000 6,832 6,532 Jan 10 08:10 PM WATKINS FRANK T Director Jan 08 '24 Sale 198.99 2,000 397,975 4,532 Jan 10 08:10 PM Godshall Douglas Evan President & CEO Jan 05 '24 Option Exercise 3.42 10,000 34,160 151,057 Jan 08 08:18 PM Godshall Douglas Evan President & CEO Jan 05 '24 Sale 200.05 10,000 2,000,500 141,057 Jan 08 08:18 PM Zacharias Isaac President, CCO Dec 26 '23 Option Exercise 6.71 3,458 23,203 45,606 Dec 28 08:35 PM Zacharias Isaac President, CCO Dec 26 '23 Sale 192.50 4,000 770,000 41,606 Dec 28 08:35 PM Godshall Douglas Evan President & CEO Dec 15 '23 Option Exercise 3.42 5,000 17,080 146,057 Dec 18 08:09 PM Godshall Douglas Evan President & CEO Dec 15 '23 Sale 187.80 5,000 938,975 141,057 Dec 18 08:09 PM PUCKETT DAN Chief Financial Officer Dec 08 '23 Sale 173.88 200 34,776 28,784 Dec 11 08:03 PM Phung Trinh VP, Finance Dec 07 '23 Sale 171.63 203 34,841 29,037 Dec 08 08:21 PM Zacharias Isaac President, CCO Nov 27 '23 Option Exercise 6.71 3,777 25,344 47,868 Nov 28 08:02 PM Zacharias Isaac President, CCO Nov 27 '23 Sale 173.58 4,000 694,320 43,868 Nov 28 08:02 PM WATKINS FRANK T Director Nov 20 '23 Option Exercise 3.42 3,000 10,248 4,532 Nov 21 08:15 PM WATKINS FRANK T Director Nov 20 '23 Sale 173.35 3,000 520,047 1,532 Nov 21 08:15 PM Godshall Douglas Evan President & CEO Nov 15 '23 Option Exercise 3.42 5,000 17,080 141,057 Nov 17 08:00 PM Godshall Douglas Evan President & CEO Nov 15 '23 Sale 174.08 5,000 870,407 136,057 Nov 17 08:00 PM Zacharias Isaac President, CCO Oct 26 '23 Option Exercise 6.71 411 2,758 48,316 Oct 30 08:02 PM Zacharias Isaac President, CCO Oct 26 '23 Sale 210.25 4,000 841,000 44,316 Oct 30 08:02 PM WATKINS FRANK T Director Oct 20 '23 Option Exercise 3.42 3,000 10,248 4,532 Oct 23 08:01 PM WATKINS FRANK T Director Oct 20 '23 Sale 202.70 3,000 608,086 1,532 Oct 23 08:01 PM Godshall Douglas Evan President & CEO Oct 16 '23 Option Exercise 3.42 10,000 34,160 151,649 Oct 17 08:10 PM Godshall Douglas Evan President & CEO Oct 16 '23 Sale 200.78 10,000 2,007,821 141,649 Oct 17 08:10 PM Zacharias Isaac President, CCO Sep 26 '23 Sale 192.12 4,000 768,480 47,905 Sep 27 07:02 PM WATKINS FRANK T Director Sep 20 '23 Option Exercise 3.42 3,000 10,248 4,532 Sep 21 08:10 PM WATKINS FRANK T Director Sep 20 '23 Sale 209.23 3,000 627,690 1,532 Sep 21 08:10 PM Godshall Douglas Evan President & CEO Sep 15 '23 Option Exercise 3.42 10,000 34,160 151,649 Sep 19 08:10 PM Godshall Douglas Evan President & CEO Sep 15 '23 Sale 212.86 10,000 2,128,615 141,649 Sep 19 08:10 PM Phung Trinh VP, Finance Aug 29 '23 Option Exercise 3.42 5,000 17,080 25,986 Aug 31 08:30 PM Zacharias Isaac President, CCO Aug 25 '23 Sale 204.98 4,000 819,920 52,446 Aug 29 08:16 PM Godshall Douglas Evan President & CEO Aug 24 '23 Option Exercise 3.42 10,000 34,160 151,649 Aug 25 08:09 PM Godshall Douglas Evan President & CEO Aug 24 '23 Sale 214.62 10,000 2,146,171 141,649 Aug 25 08:09 PM FRANCIS LAURA Director Aug 22 '23 Sale 220.97 497 109,822 3,054 Aug 23 08:07 PM WATKINS FRANK T Director Aug 21 '23 Option Exercise 3.42 3,000 10,248 4,532 Aug 22 08:14 PM WATKINS FRANK T Director Aug 21 '23 Sale 219.29 3,000 657,870 1,532 Aug 22 08:14 PM Toyloy Sara Director Aug 15 '23 Sale 223.64 100 22,364 3,673 Aug 16 08:05 PM Zacharias Isaac President, CCO Jul 26 '23 Sale 268.06 4,000 1,072,240 56,678 Jul 27 08:09 PM WATKINS FRANK T Director Jul 20 '23 Option Exercise 3.42 3,000 10,248 4,532 Jul 21 07:52 PM WATKINS FRANK T Director Jul 20 '23 Sale 267.17 3,000 801,507 1,532 Jul 21 07:52 PM Papiernik Antoine Director Jul 05 '23 Option Exercise 17.00 17,381 295,477 22,662 Jul 06 08:40 PM Zacharias Isaac President, CCO Jun 26 '23 Sale 291.84 4,000 1,167,360 60,678 Jun 26 09:11 PM Phung Trinh VP, Finance Jun 23 '23 Sale 295.91 62 18,346 21,101 Jun 26 09:09 PM WATKINS FRANK T Director Jun 20 '23 Sale 287.52 3,000 862,573 1,532 Jun 21 08:11 PM Zacharias Isaac President, CCO May 26 '23 Sale 277.53 4,000 1,110,120 65,223 May 30 08:00 PM WATKINS FRANK T Director May 22 '23 Option Exercise 3.42 3,000 10,248 6,796 May 23 08:28 PM WATKINS FRANK T Director May 22 '23 Sale 278.32 3,000 834,952 3,796 May 23 08:28 PM PUCKETT DAN Chief Financial Officer May 11 '23 Sale 291.95 2,050 598,498 29,398 May 12 08:19 PM Toyloy Sara Director May 11 '23 Sale 296.28 235 69,626 3,037 May 12 08:20 PM
Index RUT P/E - EPS (ttm) -2.12 Insider Own 4.70% Shs Outstand 50.77M Perf Week 18.09%
Market Cap 3.17B Forward P/E - EPS next Y -1.50 Insider Trans -13.00% Shs Float 48.98M Perf Month 32.63%
Income -103.37M PEG - EPS next Q -0.52 Inst Own 88.29% Short Float 10.94% Perf Quarter 30.25%
Sales 156.33M P/S 20.30 EPS this Y 13.22% Inst Trans -6.33% Short Ratio 10.06 Perf Half Y 130.46%
Book/sh 5.53 P/B 11.17 EPS next Y 22.70% ROA -30.98% Short Interest 5.36M Perf Year 116.25%
Cash/sh 4.39 P/C 14.07 EPS next 5Y 10.80% ROE -47.29% 52W Range 24.83 - 63.26 Perf YTD 47.32%
Dividend Est. - P/FCF - EPS past 5Y -23.27% ROI -30.07% 52W High -2.40% Beta 0.94
Dividend TTM - Quick Ratio 7.44 Sales past 5Y 142.74% Gross Margin 51.66% 52W Low 148.65% ATR (14) 3.02
Dividend Ex-Date - Current Ratio 8.52 EPS Y/Y TTM -14.53% Oper. Margin -80.16% RSI (14) 75.46 Volatility 6.81% 5.62%
Employees 626 Debt/Eq 0.31 Sales Y/Y TTM 83.44% Profit Margin -66.12% Recom 1.22 Target Price 58.57
Option/Short Yes / Yes LT Debt/Eq 0.30 EPS Q/Q 19.49% Payout - Rel Volume 1.92 Prev Close 60.61
Sales Surprise 7.11% EPS Surprise 8.16% Sales Q/Q 82.51% Earnings May 01 BMO Avg Volume 532.41K Price 61.74
SMA20 19.54% SMA50 24.29% SMA200 54.35% Trades
Volume 1,020,723 Change 1.86%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-11-23 Initiated Piper Sandler
Overweight
$42
May-31-23 Initiated William Blair
Outperform
Oct-31-22 Initiated BTIG Research
Neutral
Oct-25-22 Initiated Truist
Buy
$58
Sep-02-22 Initiated Wells Fargo
Overweight
$49
Jul-15-22 Initiated KeyBanc Capital Markets
Overweight
$47
Jun-23-22 Initiated B. Riley Securities
Buy
$53
Oct-11-21 Initiated SVB Leerink
Outperform
$46
Oct-11-21 Initiated Guggenheim
Buy
$45
Oct-11-21 Initiated Goldman
Neutral
$37
Oct-11-21 Initiated Cowen
Outperform
$50
Oct-11-21 Initiated BofA Securities
Buy
$48
Show Previous Ratings
Today 08:15AM
May-01-24 03:59PM
(Investor's Business Daily) +14.40%
01:53PM
12:13PM
08:25AM
07:00AM
Loading…
07:00AM
Apr-29-24 08:00AM
Apr-23-24 08:00AM
Apr-04-24 04:04PM
Apr-02-24 04:03PM
Mar-20-24 07:01PM
Mar-08-24 01:30AM
Mar-06-24 11:55PM
Feb-28-24 12:00PM
(Thomson Reuters StreetEvents)
10:00AM
04:02PM
Loading…
Feb-27-24 04:02PM
Feb-20-24 10:00AM
Feb-12-24 04:05PM
Feb-10-24 02:07AM
Feb-08-24 05:30PM
Jan-11-24 11:02PM
Jan-10-24 03:51AM
Jan-08-24 05:00PM
Dec-16-23 07:02AM
Dec-10-23 01:15AM
Dec-09-23 01:05AM
Dec-05-23 02:44PM
(Investor's Business Daily)
Nov-15-23 01:03AM
Nov-13-23 04:03PM
Nov-06-23 09:55AM
04:07PM
Loading…
Nov-02-23 04:07PM
09:33AM
(Thomson Reuters StreetEvents)
Nov-01-23 04:02PM
Oct-25-23 10:02AM
Oct-16-23 04:05PM
10:23AM
08:43AM
Oct-12-23 08:00AM
Sep-20-23 08:00AM
Sep-12-23 08:00AM
Aug-22-23 08:00AM
Aug-17-23 04:05PM
Aug-16-23 08:00AM
Aug-11-23 09:36AM
Aug-02-23 07:14AM
Aug-01-23 10:10PM
04:06PM
Jul-27-23 08:35AM
07:00AM
Jul-11-23 04:03PM
May-17-23 06:12AM
May-14-23 02:57PM
Apr-28-23 08:00AM
Apr-27-23 12:52PM
08:25AM
07:00AM
Apr-24-23 10:00AM
Apr-20-23 10:03AM
Apr-06-23 06:33AM
Apr-05-23 04:03PM
Apr-03-23 08:00AM
Mar-30-23 04:05PM
Mar-27-23 08:08AM
Mar-07-23 07:00AM
Mar-02-23 04:05PM
Mar-01-23 09:52AM
(Thomson Reuters StreetEvents)
Feb-28-23 05:25PM
04:03PM
Feb-22-23 05:33AM
Feb-16-23 09:15AM
Feb-13-23 04:02PM
Jan-09-23 08:00AM
Dec-14-22 04:05PM
Dec-12-22 03:44PM
Nov-09-22 07:32AM
Nov-03-22 05:55PM
04:03PM
Oct-27-22 10:02AM
07:37AM
Oct-12-22 08:00AM
Oct-10-22 08:00AM
Oct-04-22 10:15AM
Oct-03-22 09:16AM
Sep-19-22 08:00AM
Sep-15-22 06:15AM
Aug-22-22 04:03PM
Aug-05-22 05:30PM
Aug-04-22 04:03PM
Jul-14-22 04:02PM
Jul-10-22 08:32AM
Jun-16-22 02:30PM
(Investor's Business Daily)
Jun-09-22 09:01AM
08:00AM
May-10-22 06:20AM
May-05-22 04:02PM
Apr-28-22 08:00AM
Apr-12-22 04:02PM
Apr-11-22 08:00AM
Mar-10-22 06:03AM
Mar-08-22 04:00PM
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Zadno Reza President, CEO Mar 18 '24 Sale 48.83 5,391 263,243 241,319 Mar 20 04:46 PM Waters Kevin EVP, CFO Mar 18 '24 Sale 48.83 1,024 50,002 102,149 Mar 20 04:48 PM Nouri Alaleh EVP, CLO, CORP. SEC. Mar 18 '24 Sale 48.83 441 21,534 62,472 Mar 20 04:52 PM Shiblaq Hisham EVP, Chief Comm. Officer Mar 18 '24 Sale 48.83 244 11,915 55,860 Mar 20 04:41 PM Waters Kevin EVP, CFO Mar 15 '24 Option Exercise 4.53 53,757 243,692 103,173 Mar 18 06:05 PM Zadno Reza President, CEO Mar 06 '24 Sale 46.67 9,179 428,384 246,710 Mar 07 07:50 PM Waters Kevin EVP, CFO Mar 06 '24 Sale 46.67 3,435 160,311 49,416 Mar 07 07:51 PM Nouri Alaleh EVP, CLO, CORP. SEC. Mar 06 '24 Sale 46.67 2,749 128,296 62,913 Mar 07 07:53 PM Shiblaq Hisham EVP, Chief Comm. Officer Mar 06 '24 Sale 46.67 1,759 82,093 56,104 Mar 07 07:50 PM Krummel Thomas M Director Mar 04 '24 Sale 48.53 20,000 970,643 65,631 Mar 06 04:50 PM Waters Kevin EVP, CFO Feb 12 '24 Option Exercise 4.52 22,349 101,017 55,872 Feb 13 04:37 PM Waters Kevin EVP, CFO Feb 12 '24 Sale 50.16 22,349 1,121,062 33,523 Feb 13 04:37 PM Waters Kevin EVP, CFO Feb 09 '24 Option Exercise 4.52 28,677 129,620 62,200 Feb 09 05:09 PM Nouri Alaleh EVP, CLO, CORP. SEC. Feb 09 '24 Option Exercise 5.18 14,694 76,115 62,045 Feb 09 05:02 PM Waters Kevin EVP, CFO Feb 09 '24 Sale 50.09 28,677 1,436,379 33,523 Feb 09 05:09 PM Nouri Alaleh EVP, CLO, CORP. SEC. Feb 09 '24 Sale 49.97 14,694 734,314 47,351 Feb 09 05:02 PM Nouri Alaleh EVP, CLO, CORP. SEC. Feb 07 '24 Option Exercise 5.18 5,306 27,485 52,657 Feb 09 05:02 PM Waters Kevin EVP, CFO Feb 07 '24 Option Exercise 4.52 904 4,086 34,427 Feb 09 05:09 PM Nouri Alaleh EVP, CLO, CORP. SEC. Feb 07 '24 Sale 49.95 5,306 265,053 47,351 Feb 09 05:02 PM Waters Kevin EVP, CFO Feb 07 '24 Sale 50.00 904 45,200 33,523 Feb 09 05:09 PM Waters Kevin EVP, CFO Jan 09 '24 Option Exercise 4.52 17,310 78,241 50,833 Jan 11 05:03 PM Nouri Alaleh EVP, CLO, CORP. SEC. Jan 09 '24 Option Exercise 4.56 16,000 72,960 63,351 Jan 11 05:12 PM Waters Kevin EVP, CFO Jan 09 '24 Sale 45.07 17,310 780,247 33,523 Jan 11 05:03 PM Nouri Alaleh EVP, CLO, CORP. SEC. Jan 09 '24 Sale 44.97 16,000 719,475 47,351 Jan 11 05:12 PM Nouri Alaleh EVP, CLO, CORP. SEC. Dec 15 '23 Option Exercise 4.56 11,796 53,790 58,729 Dec 15 06:28 PM Nouri Alaleh EVP, CLO, CORP. SEC. Dec 15 '23 Sale 42.97 11,796 506,843 46,933 Dec 15 06:28 PM Nouri Alaleh EVP, CLO, CORP. SEC. Dec 14 '23 Option Exercise 4.56 3,204 14,610 50,137 Dec 15 06:28 PM Nouri Alaleh EVP, CLO, CORP. SEC. Dec 14 '23 Sale 42.95 3,204 137,618 46,933 Dec 15 06:28 PM Waters Kevin EVP, CFO Dec 13 '23 Option Exercise 4.52 71,465 323,022 104,988 Dec 15 06:19 PM Waters Kevin EVP, CFO Dec 13 '23 Sale 40.05 71,465 2,862,216 33,523 Dec 15 06:19 PM Waters Kevin EVP, CFO Dec 08 '23 Option Exercise 4.52 6,888 31,134 48,608 Dec 08 05:58 PM Waters Kevin EVP, CFO Dec 08 '23 Sale 40.02 6,888 275,640 33,523 Dec 08 05:58 PM Waters Kevin EVP, CFO Dec 07 '23 Option Exercise 4.52 3,837 17,343 41,720 Dec 08 05:58 PM Waters Kevin EVP, CFO Dec 07 '23 Sale 40.00 3,837 153,480 40,411 Dec 08 05:58 PM Nouri Alaleh EVP, CLO, CORP. SEC. Dec 06 '23 Option Exercise 4.52 6,096 27,554 53,029 Dec 08 08:05 PM Waters Kevin EVP, CFO Dec 06 '23 Option Exercise 4.52 4,360 19,707 37,883 Dec 08 05:58 PM MOLL FREDERIC H Director Dec 06 '23 Sale 38.75 79,000 3,061,355 808,233 Dec 08 05:33 PM Nouri Alaleh EVP, CLO, CORP. SEC. Dec 06 '23 Sale 39.96 6,096 243,572 46,933 Dec 08 08:05 PM Waters Kevin EVP, CFO Dec 06 '23 Sale 40.02 4,360 174,493 44,248 Dec 08 05:58 PM Wood Morgan Colby Director Nov 13 '23 Sale 32.19 25,000 804,810 112,425 Nov 14 04:12 PM Zadno Reza President, CEO Oct 18 '23 Option Exercise 4.37 5,148 22,497 200,956 Oct 18 04:28 PM Nouri Alaleh EVP, CLO, CORP. SEC. Jul 27 '23 Option Exercise 4.52 7,903 35,722 54,836 Jul 31 04:05 PM Nouri Alaleh EVP, CLO, CORP. SEC. Jul 27 '23 Sale 40.00 7,903 316,129 46,933 Jul 31 04:05 PM Waters Kevin EVP, CFO Jun 15 '23 Sale 35.12 22,631 794,912 33,523 Jun 15 05:09 PM Nouri Alaleh EVP, CLO, CORP. SEC. May 08 '23 Option Exercise 4.52 12,123 54,796 46,933 May 10 04:41 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
